You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,761,910


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,761,910
Title: Pharmaceutical composition for the treatment of acute disorders
Abstract:A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially water-soluble, in combination with the bioadhesion and/or mucoadhesion promoting agent. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
Inventor(s): Pettersson; Anders (Kode, SE), Nystrom; Christer (Uppsala, SE)
Assignee: Diabact AB (Uppsala, SE)
Application Number:09/787,888
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,761,910
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,761,910

Introduction

United States Patent 6,761,910, titled "Pharmaceutical compositions for the treatment of acute disorders by sublingual administration of an ordered mixture of microparticles with at least one pharmaceutically active agent adhered to the surfaces of the carrier," is a significant patent in the field of pharmaceuticals. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent, granted on July 13, 2004, describes a method for treating acute disorders using pharmaceutical compositions administered sublingually. These compositions consist of an ordered mixture of microparticles with at least one pharmaceutically active agent adhered to the surfaces of the carrier[2].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected.

Independent Claims

The patent includes several independent claims that define the core of the invention. For example:

  • Claim 1 describes a pharmaceutical composition comprising an ordered mixture of microparticles, each having at least one pharmaceutically active agent adhered to its surface, for sublingual administration.
  • Claim 10 outlines a method for treating an acute disorder by administering the described pharmaceutical composition sublingually[2].

Dependent Claims

Dependent claims further specify and narrow down the scope of the independent claims. These claims often describe specific embodiments, such as the type of pharmaceutically active agent, the size and material of the microparticles, and the method of preparation.

Claims Analysis

The claims of the patent are crucial for understanding what is protected and what is not.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. For instance, the term "ordered mixture of microparticles" must be defined to understand the exact nature of the composition. This could involve analyzing the specification and any relevant prior art to determine the intended meaning of this term[2].

Claim Dependency

The dependency between claims is also important. Dependent claims rely on the independent claims and add additional limitations. For example, a dependent claim might specify that the pharmaceutically active agent is fentanyl, which narrows the scope of the independent claim[2].

Prior Art and Related Patents

Understanding the prior art and related patents is essential for assessing the novelty and non-obviousness of the invention.

Relevant Prior Art

Several prior patents and publications are cited in the patent, including U.S. Pat. No. 6,759,059, which discloses compositions and methods for the treatment of acute pain by sublingual administration, and U.S. Pat. No. 6,252,981, which describes oral mucosal drug delivery as an alternative method of systemic drug delivery formulation[2].

Global Patent Landscape

The global patent landscape for similar inventions can be explored using databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE® Search Service. These resources help in identifying similar patents and applications filed in other jurisdictions, which can impact the global protection and enforcement of the patent[1].

Economic and Innovation Impact

The economic and innovation impact of this patent can be significant, especially in the pharmaceutical industry.

Patenting Activity

The patent is part of a larger trend in pharmaceutical patenting, where companies and individuals seek to protect their inventions to gain economic benefits. According to the USPTO, the private sector, particularly for-profit companies, receives the majority of patents in the U.S., reflecting the commercial importance of such inventions[4].

Industry-Level Impact

The patent's impact extends to knowledge- and technology-intensive industries, such as high-technology manufacturing and commercial knowledge-intensive services. These industries have a larger share of patents and are more likely to engage in experimental development activities, leading to direct commercial applications of their research[4].

Legal and Regulatory Considerations

The legal and regulatory environment surrounding the patent is crucial for its enforcement and protection.

Patent Protection

The patent provides the legal right to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the technical information. This protection is essential for the economic motivations of inventors and companies[4].

Litigation and Enforcement

The patent could be involved in litigation if there are allegations of infringement. For example, a case might involve determining whether another company's product infringes on one or more of the claims of the '910 patent. This would require a detailed analysis of the claims and the accused product to determine infringement[5].

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, which specify the pharmaceutical composition and method of administration.
  • Prior Art and Related Patents: Understanding prior art and related patents is crucial for assessing novelty and non-obviousness.
  • Global Patent Landscape: The global landscape includes similar patents and applications in other jurisdictions.
  • Economic and Innovation Impact: The patent has significant economic and innovation implications, particularly in the pharmaceutical industry.
  • Legal and Regulatory Considerations: The patent's legal protection and potential litigation are important for its enforcement.

FAQs

Q: What is the main subject of United States Patent 6,761,910? A: The main subject is a pharmaceutical composition for treating acute disorders through sublingual administration of an ordered mixture of microparticles with at least one pharmaceutically active agent adhered to the surfaces of the carrier.

Q: How do the claims of the patent define its scope? A: The claims define the specific aspects of the invention, including the composition and method of administration, with independent claims outlining the core of the invention and dependent claims adding additional limitations.

Q: What is the significance of prior art in analyzing this patent? A: Prior art helps in assessing the novelty and non-obviousness of the invention by comparing it with existing patents and publications.

Q: How does this patent fit into the global patent landscape? A: It is part of a broader landscape of similar patents and applications filed in various jurisdictions, which can impact its global protection and enforcement.

Q: What are the economic implications of this patent? A: The patent has significant economic implications, particularly in the pharmaceutical industry, where it can provide exclusive rights to the inventor or assignee, influencing commercial applications and innovation.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US20080166404A1: https://patents.google.com/patent/US20080166404A1/en
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NSF - Chapter 8 - Invention, Knowledge Transfer, and Innovation: https://www.nsf.gov/statistics/2018/nsb20181/report/sections/invention-knowledge-transfer-and-innovation/invention-united-states-and-comparative-global-trends
  5. RPX Insight - Case 3:15-cv-00826-PGS-DEA Document 1 Filed 02: https://insight.rpxcorp.com/litigation_documents/11154862

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,761,910

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,761,910

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9803240Sep 24, 1998
PCT Information
PCT FiledSeptember 24, 1999PCT Application Number:PCT/SE99/01687
PCT Publication Date:March 30, 2000PCT Publication Number: WO00/16750

International Family Members for US Patent 6,761,910

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2236132 ⤷  Subscribe C300714 Netherlands ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe CA 2015 00004 Denmark ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 92636 Luxembourg ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 122015000006 Germany ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.